|Allen A. Spizzo
Pharmaceutical, Biotech & Chemicals Industry Expert
Allen is a business and management consultant focused on the chemicals, materials, biotechnology and pharmaceutical industries, and he serves as an investment adviser and asset management trustee. Allen served as Vice President and CFO of Hercules Inc., a former S&P 500 specialty chemicals company, from 2004 until the company was sold to Ashland Inc. in 2008. His work with Hercules began in 1979 and spanned roles as VP Corporate Affairs, Strategic Planning and Corporate Development, as well as VP Investor Relations and Strategic Planning. Allen received his BS in Chemical Engineering from North Carolina State University and an MBA from University of Akron.
|Amelia Wall Warner
Founder and CEO, Global Specimen Solutions, Inc.
Amelia is the founder and CEO of Global Specimen Solutions (GSS), with decades of experience with big pharmaceutical companies. Prior to GSS, Amelia served as CEO, President and Director of the Board for Gentris Corporation. Amelia served as Head of Clinical Pharmacogenomics and Clinical Specimen Management for Merck Research Laboratories (MRL), as well as MRL Pharmacogenomics Expert for the Translational Science Research Network. She was the MRL Key Expert for Global Regulation for Genetic Research and Human Specimen Usage Regulation/Law. She served as Chair of the Industry Pharmacogenomics Working Group (I-PWG) and a PhRMA Representative to ICH E16- Genomic Biomarkers Related to Drug Response.
Amelia completed a Residency in Pediatric Pharmacotherapy at St. Jude Children’s Research Hospital and a Fellowship in Clinical Pharmacology/Pharmacogenomics at St. Jude Children’s Research Hospital with William Evans, PharmD. Dr. Warner holds a BS in Biology from Wake Forest University and her PharmD from the University of North Carolina at Chapel Hill.